Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Atkins

Showing results (41-50 of 338) with videos related to

Pageof 34
Sort By:
Expert Opinion on Biological Therapy|April 23, 2004
Application of IL-2 and other cytokines in renal cancerDavid F McDermott, Michael B Atkins
Seminars in Oncology|October 19, 2006
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of responseDavid F McDermott, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Nature Reviews. Drug Discovery|July 2, 2009
EverolimusMichael B Atkins, Uma Yasothan, Peter Kirkpatrick
Nature Reviews. Urology|February 6, 2020
Checkpoint inhibitor immunotherapy in kidney cancerWenxin Xu, Michael B Atkins, David F McDermott
Cancer Management and Research|December 29, 2010
Management of metastatic renal cell carcinoma in patients with poor prognosisAndrea Bullock, David F McDermott, Michael B Atkins
Journal for Immunotherapy of Cancer|March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinomaBrian I Rini, James Brugarolas, Michael B Atkins
The New England Journal of Medicine|September 3, 2004
Management of cutaneous melanomaHensin Tsao, Michael B Atkins, Arthur J Sober
Expert Opinion on Biological Therapy|December 19, 2003
18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USAFrancesco M Marincola, Ena Wang, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancerJeffrey A Sosman, Igor Puzanov, Michael B Atkins
Pageof 34

Showing results (41-50 of 338) with videos related to

Sort By:
Pageof 34
Expert Opinion on Biological Therapy|April 23, 2004
Application of IL-2 and other cytokines in renal cancerDavid F McDermott, Michael B Atkins
Seminars in Oncology|October 19, 2006
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of responseDavid F McDermott, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Nature Reviews. Drug Discovery|July 2, 2009
EverolimusMichael B Atkins, Uma Yasothan, Peter Kirkpatrick
Nature Reviews. Urology|February 6, 2020
Checkpoint inhibitor immunotherapy in kidney cancerWenxin Xu, Michael B Atkins, David F McDermott
Cancer Management and Research|December 29, 2010
Management of metastatic renal cell carcinoma in patients with poor prognosisAndrea Bullock, David F McDermott, Michael B Atkins
Journal for Immunotherapy of Cancer|March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinomaBrian I Rini, James Brugarolas, Michael B Atkins
The New England Journal of Medicine|September 3, 2004
Management of cutaneous melanomaHensin Tsao, Michael B Atkins, Arthur J Sober
Expert Opinion on Biological Therapy|December 19, 2003
18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USAFrancesco M Marincola, Ena Wang, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancerJeffrey A Sosman, Igor Puzanov, Michael B Atkins
Pageof 34